ArticleBMJ open2023

Impact of polyethylene glycol loxenatide on cardiovascular outcomes in patients with type 2 diabetes: study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (BALANCE-3).

Yun Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.